← Leaderboards
Paul B McCray
University Of Iowa
$33,563,463
Attributed
$35,757,231
Total exposure
36
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,636,198 · 38
By mechanism
P01$51,445,616 · 18
R01$6,097,733 · 5
P50$2,848,180 · 2
UH3$2,297,248 · 1
UG3$2,062,335 · 1
P30$1,325,865 · 4
Top collaborators
- David A Stoltz4 shared
- Patrick L Sinn2 shared
- Yi Xing2 shared
- Mark R Ackermann1 shared
- Michael A. Apicella1 shared
- David E Cohen1 shared
- John F Engelhardt1 shared
- Timothy S Frana1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Botond Banfi$6,604,080
- Beverly L Davidson$40,254,264
- Patrick L Sinn$13,054,693
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
- Dean R Madden · Dartmouth College$23,788,969
Research focus
Cystic FibrosisLungLung DiseasesAirway EpitheliumCellsIn VivoGene TherapyIn VitroPulmonary Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorProgramsEpitheliumFamily SuidaeCell TypeProteinsEpithelial CellsPathogenesisSurfaceInfectionInflammationResearch PersonnelVectorAnimal ModelBase
Grant awards (133)
Adenine Base Edited Correction of Cystic Fibrosis Airways$688,492
R01 · FY2025 · HL
Project 3$393,847
P01 · FY2025 · HL · contact PI
Molecular Therapies for Cystic Fibrosis Lung Disease$2,265,385
P01 · FY2024 · HL · contact PI
Adenine Base Edited Correction of Cystic Fibrosis Airways$588,142
R01 · FY2024 · HL
Gene Editing Strategies to Correct CFTR Mutations$434,516
P01 · FY2024 · HL · contact PI
Iowa StARR Scholars Program$322,361
R38 · FY2024 · HL
Impact of ATP-binding cassette A3 (ABCA3) mutations on alveolar type 2 cell function and genetic complementation$173,175
R03 · FY2024 · TR · contact PI
Administration Core$47,468
P01 · FY2024 · HL · contact PI
Molecular Therapies for Cystic Fibrosis Lung Disease$2,311,617
P01 · FY2023 · HL · contact PI
Gene Editing Strategies to Correct CFTR Mutations$441,120
P01 · FY2023 · HL · contact PI
Iowa StARR Scholars Program$322,361
R38 · FY2023 · HL
Administration Core$54,074
P01 · FY2023 · HL · contact PI
Molecular Therapies for Cystic Fibrosis Lung Disease$2,311,617
P01 · FY2022 · HL · contact PI
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides$889,032
UH3 · FY2022 · HL · contact PI
SCGE Disease Models Studies Supplement: Repair of a CFTR Nonsense Mutation Using Adenine Base Editing$490,858
UH3 · FY2022 · HL · contact PI
Gene Editing Strategies to Correct CFTR Mutations$441,120
P01 · FY2022 · HL · contact PI
Iowa StARR Scholars Program$322,426
R38 · FY2022 · HL
Administration Core$54,074
P01 · FY2022 · HL · contact PI
Molecular Therapies for Cystic Fibrosis Lung Disease$2,320,230
P01 · FY2021 · HL · contact PI
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides$917,358
UH3 · FY2021 · HL · contact PI
Gene Editing Strategies to Correct CFTR Mutations$441,120
P01 · FY2021 · HL · contact PI
Project-003$340,075
P01 · FY2021 · AI · contact PI
Iowa StARR Scholars Program$324,448
R38 · FY2021 · HL
Administration Core$54,075
P01 · FY2021 · HL · contact PI
Molecular Therapies for Cystic Fibrosis Lung Disease$2,363,383
P01 · FY2020 · HL · contact PI
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides$691,279
UG3 · FY2020 · HL · contact PI
Gene Editing Strategies to Correct CFTR Mutations$468,370
P01 · FY2020 · HL · contact PI
Project-003$340,075
P01 · FY2020 · AI · contact PI
Administration Core$54,075
P01 · FY2020 · HL · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease$2,199,723
P01 · FY2019 · HL · contact PI
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides$685,879
UG3 · FY2019 · HL · contact PI
Project 3$340,075
P01 · FY2019 · AI · contact PI
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors$313,180
P01 · FY2019 · HL · contact PI
Vector Core$167,750
P30 · FY2019 · DK · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core$53,200
P01 · FY2019 · HL · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease$2,201,579
P01 · FY2018 · HL · contact PI
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides$685,177
UG3 · FY2018 · HL · contact PI
Project 3$340,032
P01 · FY2018 · AI · contact PI
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors$313,180
P01 · FY2018 · HL · contact PI
Vector Core$167,707
P30 · FY2018 · DK · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core$53,200
P01 · FY2018 · HL · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease$2,203,382
P01 · FY2017 · HL · contact PI
Mining a microRNA Regulated Gene Network to Rescue CFTR-DeltaF508 Function$415,658
R01 · FY2017 · HL · contact PI
Respiratory virus infection in early cystic fibrosis lung disease$347,300
P01 · FY2017 · HL · contact PI
Project 3$340,075
P01 · FY2017 · AI · contact PI
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors$313,180
P01 · FY2017 · HL · contact PI
Vector Core$168,188
P30 · FY2017 · DK · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core$53,200
P01 · FY2017 · HL · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease$2,219,200
P01 · FY2016 · HL · contact PI
Mining a microRNA Regulated Gene Network to Rescue CFTR-DeltaF508 Function$479,321
R01 · FY2016 · HL · contact PI
Respiratory virus infection in early cystic fibrosis lung disease$347,300
P01 · FY2016 · HL · contact PI
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors$312,409
P01 · FY2016 · HL · contact PI
Vector Core$167,652
P30 · FY2016 · DK · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core$53,070
P01 · FY2016 · HL · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease$2,216,878
P01 · FY2015 · HL · contact PI
Mining a microRNA Regulated Gene Network to Rescue CFTR-DeltaF508 Function$472,131
R01 · FY2015 · HL · contact PI
Respiratory virus infection in early cystic fibrosis lung disease$342,996
P01 · FY2015 · HL · contact PI
Gene Transfer to Porcine Respiratory Epithelia with Viral Vectors$310,100
P01 · FY2015 · HL · contact PI
Biology of ACE2 activity in the airway epithelium$287,168
P01 · FY2015 · AI · contact PI
Vector Core$166,100
P30 · FY2015 · DK · contact PI
Gene Therapy For Cystic Fibrosis Lung Disease - Administration Core$52,676
P01 · FY2015 · HL · contact PI
Mining a microRNA Regulated Gene Network to Rescue CFTR-DeltaF508 Function$492,313
R01 · FY2014 · HL · contact PI
Respiratory virus infection in early cystic fibrosis lung disease$341,549
P01 · FY2014 · HL · contact PI
Biology of ACE2 activity in the airway epithelium$304,341
P01 · FY2014 · AI · contact PI
Vector Core$150,754
P30 · FY2014 · DK · contact PI
PPG - Gene Therapy for Cystic Fibrosis Lung Disease$2,159,794
P01 · FY2013 · HL · contact PI
Respiratory virus infection in early cystic fibrosis lung disease$330,626
P01 · FY2013 · HL · contact PI
Biology of ACE2 activity in the airway epithelium$285,870
P01 · FY2013 · AI · contact PI
Lentiviral gene tranfer to porcine airway epithelia$269,975
P01 · FY2013 · HL · contact PI
Administrative Core$269,973
P01 · FY2013 · HL · contact PI
Epitope targeted AAVS for improved airway delivery$179,690
R21 · FY2013 · HL · contact PI
PPG - Gene Therapy for Cystic Fibrosis Lung Disease$2,268,494
P01 · FY2012 · HL · contact PI
Biology of ACE2 activity in the airway epithelium$297,872
P01 · FY2012 · AI · contact PI
Early lung inflammation in a porcine model of cystic fibrosis$295,983
P01 · FY2012 · HL · contact PI
Lentiviral gene tranfer to porcine airway epithelia$283,562
P01 · FY2012 · HL · contact PI
Administrative Core$283,561
P01 · FY2012 · HL · contact PI
Cell Morphology and Pathology Core$168,881
P30 · FY2012 · DK · contact PI
PPG - Gene Therapy for Cystic Fibrosis Lung Disease$2,262,564
P01 · FY2011 · HL · contact PI
Antiviral properties of an oxidative host defense system of the airways$558,677
R56 · FY2011 · AI
Etiology of Cystic Fibrosis-Related Diabetes in a CFTR-knockout Ferret$485,396
R24 · FY2011 · DK
Biology of ACE2 activity in the airway epithelium$302,719
P01 · FY2011 · AI · contact PI
Early lung inflammation in a porcine model of cystic fibrosis$295,983
P01 · FY2011 · HL · contact PI
Administrative Core$282,821
P01 · FY2011 · HL · contact PI
Lentiviral gene tranfer to porcine airway epithelia$282,820
P01 · FY2011 · HL · contact PI
Altered microRNA function in cystic fibrosis airway epithelia$187,437
R21 · FY2011 · HL · contact PI
PPG - Gene Therapy for Cystic Fibrosis Lung Disease$2,266,223
P01 · FY2010 · HL · contact PI
Early lung inflammation in a porcine model of cystic fibrosis$295,983
P01 · FY2010 · HL · contact PI
Administrative Core$283,278
P01 · FY2010 · HL · contact PI
Lentiviral gene tranfer to porcine airway epithelia$283,277
P01 · FY2010 · HL · contact PI
Altered microRNA function in cystic fibrosis airway epithelia$223,750
R21 · FY2010 · HL · contact PI
PPG - Gene Therapy for Cystic Fibrosis Lung Disease$2,308,898
P01 · FY2009 · HL · contact PI
Early lung inflammation in a porcine model of cystic fibrosis$295,983
P01 · FY2009 · HL · contact PI
Administrative Core$288,613
P01 · FY2009 · HL · contact PI
Lentiviral gene tranfer to porcine airway epithelia$288,612
P01 · FY2009 · HL · contact PI
Allele-Specific Repair of the CFTR DeltaF508 Mutation using Zinc Finger Nucleases$244,000
R21 · FY2009 · HL · contact PI
Cell Morphology and Pathology Core$168,833
P30 · FY2009 · DK · contact PI
Interaction of SARS-CoV with the Human Airway Epithelium$313,118
P01 · FY2008 · AI · contact PI
Targeting Entry in Epithelia with ICMV-FIV$307,714
P01 · FY2008 · HL · contact PI
Early lung inflammation in a porcine model of cystic fibrosis$293,233
P01 · FY2008 · HL · contact PI
Enhancing hepatocyte gene transfer for Hemophilia A$274,118
R01 · FY2008 · HL · contact PI
Allele-Specific Repair of the CFTR DeltaF508 Mutation using Zinc Finger Nucleases$215,500
R21 · FY2008 · HL · contact PI
Innate Immune Properties of Airway Epithelial Antimicrobial Proteins and Peptides$481,230
P50 · FY2007 · HL · contact PI
Filovirus enveloped FIV:virus-epithelia interactions-CF$349,641
R01 · FY2007 · HL · contact PI
Targeting Entry in Epithelia with ICMV-FIV$322,128
P01 · FY2007 · HL · contact PI
Interaction of SARS-CoV with the Human Airway Epithelium$313,118
P01 · FY2007 · AI · contact PI
Enhancing hepatocyte gene transfer for Hemophilia A$279,713
R01 · FY2007 · HL · contact PI
Filovirus enveloped FIV:virus-epithelia interactions-CF$360,084
R01 · FY2006 · HL · contact PI
Interaction of SARS-CoV with the Human Airway Epithelium$320,999
P01 · FY2006 · AI · contact PI
Innate Immune Properties of Airway Epithelium$300,642
P50 · FY2006 · HL · contact PI
Enhancing hepatocyte gene transfer for Hemophilia A$288,068
R01 · FY2006 · HL · contact PI
Targeting Entry in Epithelia with ICMV-FIV$213,578
P01 · FY2006 · HL · contact PI
Filovirus enveloped FIV:virus-epithelia interactions-CF$368,750
R01 · FY2005 · HL
Interaction of SARS-CoV with the Human Airway Epithelium$311,884
P01 · FY2005 · AI
Enhancing hepatocyte gene transfer for Hemophilia A$295,000
R01 · FY2005 · HL
Innate Immune Properties of Airway Epithelium$292,385
P50 · FY2005 · HL
Targeting Entry in Epithelia with ICMV-FIV$208,212
P01 · FY2005 · HL
Filovirus enveloped FIV:virus-epithelia interactions-CF$368,750
R01 · FY2004 · HL
Interaction of SARS-CoV with the Human Airway Epithelium$317,981
P01 · FY2004 · AI
Innate Immune Properties of Airway Epithelium$283,383
P50 · FY2004 · HL
Targeting Entry in Epithelia with ICMV-FIV$192,405
P01 · FY2004 · HL
Innate Immune Properties of Airway Epithelium$260,882
P50 · FY2003 · HL
GENE TRANSFER TO HUMAN AIRWAY EPITHELIA IN VIVO$290,033
P01 · FY2002 · HL
EXPRESSION AND ACTIVITY OF HUMAN AIRWAY BETA DEFENSINS$243,516
P50 · FY2002 · HL
DEVELOPMENTAL REGULATION OF ENAC EXPRESSION$144,729
P50 · FY2002 · DK
RETROVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$129,588
R01 · FY2002 · HL
GENE TRANSFER TO HUMAN AIRWAY EPITHELIA IN VIVO$290,033
P01 · FY2001 · HL
EXPRESSION AND ACTIVITY OF HUMAN AIRWAY BETA DEFENSINS$243,516
P50 · FY2001 · HL
DEVELOPMENTAL REGULATION OF ENAC EXPRESSION$144,729
P50 · FY2001 · DK
RETROVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$125,814
R01 · FY2001 · HL
EXPRESSION AND ACTIVITY OF HUMAN AIRWAY BETA DEFENSINS$293,069
P50 · FY2000 · HL
GENE TRANSFER TO HUMAN AIRWAY EPITHELIA IN VIVO$272,462
P01 · FY2000 · HL
DEVELOPMENTAL REGULATION OF ENAC EXPRESSION$160,099
P50 · FY2000 · DK
RETROVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$122,150
R01 · FY2000 · HL